Avanos Medical Inc (AVNS) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access AVNS Annual Balance Sheets →
A period-by-period view of the balance sheet from Avanos Medical Inc to Mar 31 2025 helps clarify how Mar 31 2026's financial structure has changed over time.
Quarterly Report, GAAP in USD millions
ITEM
(Mar 31 2026)
(Dec 31 2025) (Sep 30 2025) (Jun 30 2025) (Mar 31 2025)
Assets
Cash & cash equivalent65.60
Cash & Short-term Investments65.00
Accounts receivable103.00
Inventories141.30
Prepaid Expense And Other Assets Current15.10
Total Current Assets325.00
Equipment/Property/Plant Net111.20
Goodwill net394.00
Intangible Assets114.70
Other Assets, Noncurrent105.20
Deferred Income Tax Assets Net33.00
Total Assets1,050.10
Liabilities
Accounts Payable, Current AC52.30
Accrued Liabilities, Current AC57.60
Long-term Debt, Current Maturities LO10.90
Total Current Liabilities131.20
Long-term debt87.30
Total Long-term Debt87.30
Other liabilities, Noncurrent59.90
Deferred Income Tax Liabilities Net5.60
Total Liabilities268.00
Stockholders' Equity
Treasury Stock Common Value-103.60
Common Stock Value0.50
Additional Paid In Capital Common Stock1,696.00
Retained Earnings / Accumulated Deficit-774.80
Other Equity-36.00
Common Stockholder's Equity782.10
Total Stockholder's Equity782.10
Liabilities & Stockholder's Equity1,050.10
4 historic quarters locked

Sign in to unlock the full Avanos Medical Inc balance sheet history.

About Avanos Medical Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001606498-26-000063

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.